488 related articles for article (PubMed ID: 23948576)
21. (C^N
Williams M; Green AI; Fernandez-Cestau J; Hughes DL; O'Connell MA; Searcey M; Bertrand B; Bochmann M
Dalton Trans; 2017 Oct; 46(39):13397-13408. PubMed ID: 28945262
[TBL] [Abstract][Full Text] [Related]
22. Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents.
Messori L; Marchetti L; Massai L; Scaletti F; Guerri A; Landini I; Nobili S; Perrone G; Mini E; Leoni P; Pasquali M; Gabbiani C
Inorg Chem; 2014 Mar; 53(5):2396-403. PubMed ID: 24547701
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and structure of dicopper(II) complexes bridged by N-(5-chloro-2-hydroxyphenyl)-N'-[3-(methy lamino)propyl]oxamide: evaluation of DNA/protein binding, DNA cleavage, and in vitro anticancer activity.
Xu XW; Li XJ; Zhu L; Li YT; Wu ZY; Yan CW
J Photochem Photobiol B; 2015 Jun; 147():9-23. PubMed ID: 25837411
[TBL] [Abstract][Full Text] [Related]
24. High in vitro and in vivo antitumor activities of Ln(III) complexes with mixed 5,7-dichloro-2-methyl-8-quinolinol and 4,4'-dimethyl-2,2'-bipyridyl chelating ligands.
Meng T; Qin QP; Chen ZL; Zou HH; Wang K; Liang FP
Eur J Med Chem; 2019 May; 169():103-110. PubMed ID: 30870791
[TBL] [Abstract][Full Text] [Related]
25. Cellular pharmacological properties of gold(III) porphyrin 1a, a potential anticancer drug lead.
Wang Y; He QY; Sun RW; Che CM; Chiu JF
Eur J Pharmacol; 2007 Jan; 554(2-3):113-22. PubMed ID: 17116302
[TBL] [Abstract][Full Text] [Related]
26. Vanadium polypyridyl compounds as potential antiparasitic and antitumoral agents: new achievements.
Benítez J; Becco L; Correia I; Leal SM; Guiset H; Pessoa JC; Lorenzo J; Tanco S; Escobar P; Moreno V; Garat B; Gambino D
J Inorg Biochem; 2011 Feb; 105(2):303-12. PubMed ID: 21194632
[TBL] [Abstract][Full Text] [Related]
27. In vitro antitumor activity, metal uptake and reactivity with ascorbic acid and BSA of some gold(III) complexes with N,N'-ethylenediamine bidentate ester ligands.
Pantelić N; Zmejkovski BB; Kolundžija B; Crnogorac MĐ; Vujić JM; Dojčinović B; Trifunović SR; Stanojković TP; Sabo TJ; Kaluđerović GN
J Inorg Biochem; 2017 Jul; 172():55-66. PubMed ID: 28433833
[TBL] [Abstract][Full Text] [Related]
28. Cu(II) complexes with co-planar [Cu(II)(N-N)(HIMC⁻)], their anti-cancer activities, ΔG, ΔE and solid luminescence.
Cheng YF; Lu XM; Wang G
Dalton Trans; 2014 Apr; 43(14):5357-63. PubMed ID: 24519174
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, spectroscopic characterization, electrochemical behavior and computational analysis of mixed diamine ligand gold(III) complexes: antiproliferative and in vitro cytotoxic evaluations against human cancer cell lines.
Al-Jaroudi SS; Monim-ul-Mehboob M; Altaf M; Al-Saadi AA; Wazeer MI; Altuwaijri S; Isab AA
Biometals; 2014 Dec; 27(6):1115-36. PubMed ID: 25034122
[TBL] [Abstract][Full Text] [Related]
30. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, characterization, cytotoxicity and antimicrobial studies on bis(N-furfuryl-N-(2-phenylethyl)dithiocarbamato-S,S')zinc(II) and its nitrogen donor adducts.
Rani PJ; Thirumaran S
Eur J Med Chem; 2013 Apr; 62():139-47. PubMed ID: 23353751
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, structural characterization, docking simulation and in vitro antiproliferative activity of the new gold(III) complex with 2-pyridineethanol.
Malik M; Bieńko DC; Komarnicka UK; Kyzioł A; Dryś M; Świtlicka A; Dyguda-Kazimierowicz E; Jedwabny W
J Inorg Biochem; 2021 Feb; 215():111311. PubMed ID: 33246642
[TBL] [Abstract][Full Text] [Related]
33. A series of mononuclear Co(III) complexes using tridentate N,O-donor ligands: chemical properties and cytotoxicity activity.
Souza ET; Maia PJ; Azevedo EM; Kaiser CR; Resende JA; Pinheiro CB; Heinrich TA; da Silva RS; Scarpellini M
J Inorg Biochem; 2011 Dec; 105(12):1767-73. PubMed ID: 22001498
[TBL] [Abstract][Full Text] [Related]
34. Anticancer Gold(III) Peptidomimetics: From Synthesis to in vitro and ex vivo Biological Evaluations.
Boscutti G; Nardon C; Marchiò L; Crisma M; Biondi B; Dalzoppo D; Dalla Via L; Formaggio F; Casini A; Fregona D
ChemMedChem; 2018 Jun; 13(11):1131-1145. PubMed ID: 29570944
[TBL] [Abstract][Full Text] [Related]
35. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation.
Garza-Ortiz A; den Dulk H; Brouwer J; Kooijman H; Spek AL; Reedijk J
J Inorg Biochem; 2007 Nov; 101(11-12):1922-30. PubMed ID: 17637477
[TBL] [Abstract][Full Text] [Related]
36. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
[TBL] [Abstract][Full Text] [Related]
37. Structure and properties of neutral and cationic gold(III) complexes from substituted 2-(2'-pyridyl)quinoline ligands.
Laguna EM; Olsen PM; Sterling MD; Eichler JF; Rheingold AL; Larsen CH
Inorg Chem; 2014 Dec; 53(23):12231-3. PubMed ID: 25390894
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts.
Cattaruzza L; Fregona D; Mongiat M; Ronconi L; Fassina A; Colombatti A; Aldinucci D
Int J Cancer; 2011 Jan; 128(1):206-15. PubMed ID: 20209498
[TBL] [Abstract][Full Text] [Related]
39. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents.
Schuh E; Pflüger C; Citta A; Folda A; Rigobello MP; Bindoli A; Casini A; Mohr F
J Med Chem; 2012 Jun; 55(11):5518-28. PubMed ID: 22621714
[TBL] [Abstract][Full Text] [Related]
40. Overcoming cisplatin resistance using gold(III) mimics: anticancer activity of novel gold(III) polypyridyl complexes.
Palanichamy K; Sreejayan N; Ontko AC
J Inorg Biochem; 2012 Jan; 106(1):32-42. PubMed ID: 22112837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
